Laura Albini

Summary

Publications

  1. doi request reprint Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era
    Laura Albini
    Department of Infectious Diseases, University of Brescia, Brescia, Italy
    AIDS Res Hum Retroviruses 29:1097-104. 2013
  2. doi request reprint Increase in standard cholesterol and large HDL particle subclasses in antiretroviral-naïve patients prescribed efavirenz compared to atazanavir/ritonavir
    Daria Gotti
    Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    HIV Clin Trials 13:245-55. 2012
  3. pmc Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz
    Emanuele Focà
    Infectious Diseases Department, University of Brescia, Brescia, Italy
    BMC Infect Dis 12:38. 2012
  4. doi request reprint Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy
    Daria Gotti
    University Division of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    AIDS Patient Care STDS 27:259-65. 2013
  5. ncbi request reprint Impact of detectable human cytomegalovirus DNAemia on viro-immunological effectiveness of HAART in HIV-infected patients naive to antiretroviral therapy
    Emanuele Focà
    Infectious Diseases Department, University of Brescia, Brescia, Italy
    New Microbiol 35:227-31. 2012
  6. pmc Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study
    Daria Gotti
    University Division of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    PLoS ONE 9:e94768. 2014
  7. doi request reprint A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz
    Laura Albini
    Department of Materno Infantile e Tecnologie Biomediche, Institute of Infectious and Tropical Diseases, University of Brescia, Italy
    J Acquir Immune Defic Syndr 59:18-30. 2012
  8. doi request reprint Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection
    Monia Mendeni
    Institute of Infectious and Tropical Diseases, University of Brescia, Italy
    Clin Infect Dis 52:1164-73. 2011

Collaborators

Detail Information

Publications8

  1. doi request reprint Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era
    Laura Albini
    Department of Infectious Diseases, University of Brescia, Brescia, Italy
    AIDS Res Hum Retroviruses 29:1097-104. 2013
    ..98, p=0.057). HIV-infected men showed a 2-fold increased risk of non-virus-related NADCs compared to the general population. However, the use of cART appeared to be beneficial in protecting against the development of these malignancies...
  2. doi request reprint Increase in standard cholesterol and large HDL particle subclasses in antiretroviral-naïve patients prescribed efavirenz compared to atazanavir/ritonavir
    Daria Gotti
    Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    HIV Clin Trials 13:245-55. 2012
    ..Lipoprotein-particle subclasses may also have an effect, but comparative data after standard HAART regimens are limited...
  3. pmc Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz
    Emanuele Focà
    Infectious Diseases Department, University of Brescia, Brescia, Italy
    BMC Infect Dis 12:38. 2012
    ..Lastly, the effect of tenofovir on 1,25-(OH)₂ vitamin D is uncertain...
  4. doi request reprint Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy
    Daria Gotti
    University Division of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    AIDS Patient Care STDS 27:259-65. 2013
    ..37 cells/μL for controls, p<0.0001). Compared with the general population, HIV-infected patients showed an increased risk for developing HL. The risk of HIV-HL increased significantly in the first months after cART initiation...
  5. ncbi request reprint Impact of detectable human cytomegalovirus DNAemia on viro-immunological effectiveness of HAART in HIV-infected patients naive to antiretroviral therapy
    Emanuele Focà
    Infectious Diseases Department, University of Brescia, Brescia, Italy
    New Microbiol 35:227-31. 2012
    ..At the same time, HAART proved effective in reducing HCMV DNAemia without the need for a specific therapy...
  6. pmc Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study
    Daria Gotti
    University Division of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    PLoS ONE 9:e94768. 2014
    ..We studied survival and associated risk factors in an Italian nationwide cohort of HIV-infected individuals after an AIDS-defining cancer (ADC) or non-AIDS-defining cancer (NADC) diagnosis in the modern cART era...
  7. doi request reprint A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz
    Laura Albini
    Department of Materno Infantile e Tecnologie Biomediche, Institute of Infectious and Tropical Diseases, University of Brescia, Italy
    J Acquir Immune Defic Syndr 59:18-30. 2012
    ..There is lack of data on GFR estimated by these methods in patients on highly active antiretroviral therapy...
  8. doi request reprint Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection
    Monia Mendeni
    Institute of Infectious and Tropical Diseases, University of Brescia, Italy
    Clin Infect Dis 52:1164-73. 2011
    ..There is lack of data on the incidence of liver fibrosis (LF) progression in patients with human immunodeficiency virus (HIV) monoinfection and risk factors for LF...